XML 22 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Derivatives (Table Text Block)
3 Months Ended
Jun. 30, 2015
Derivative Instrument Detail [Abstract]  
Derivatives

 

Original variable rate debt and lease amount

 

Agreement Date

 

Effective Date

 

Expiration Date

 

Designated cash flow hedge date

 

(Unaudited)

 

 

 

 

 

 

 

 

 

(In millions)

 

 

 

 

 

 

 

 

$

300.0

 

 

8/16/2006

 

8/18/2006

 

8/10/2018

 

8/4/2006

 

19.0

 

 

8/27/2008

 

8/29/2008

 

7/10/2015

 

4/10/2008

 

30.0

 

 

9/24/2008

 

9/30/2008

 

9/10/2015

 

9/24/2008

 

15.0

(a)

 

3/24/2009

 

3/30/2009

 

3/30/2016

 

3/25/2009

 

14.7

(a)

 

7/6/2010

 

8/15/2010

 

7/15/2017

 

7/6/2010

 

25.0

(a)

 

4/26/2011

 

6/1/2011

 

6/1/2018

 

6/1/2011

 

50.0

(a)

 

7/29/2011

 

8/15/2011

 

8/15/2018

 

7/29/2011

 

20.0

(a)

 

8/3/2011

 

9/12/2011

 

9/10/2018

 

8/3/2011

 

15.1

(b)

 

3/27/2012

 

3/28/2012

 

3/28/2019

 

3/26/2012

 

25.0

 

 

4/13/2012

 

4/16/2012

 

4/1/2019

 

4/12/2012

 

44.3

 

 

1/11/2013

 

1/15/2013

 

12/15/2019

 

1/11/2013

(a) forward swaps

(b) operating lease

Derivative Fair Values Located in Accounts Payable and Accrued Expenses in the Balance Sheet

 

 

Net Liability Derivative Fair Value as of

 

 

June 30, 2015

 

March 31, 2015

 

 

(Unaudited)

 

 

 

 

(In thousands)

Interest rate contracts designated as hedging instruments

$

21,121

$

24,484

 

Effect of Interest Rate Contracts on the Statement of Operations

 

 

The Effect of Interest Rate

 

 

Contracts on the Statements of Operations

 

 

Quarter Ended June 30,

 

 

2015

 

2014

 

 

(Unaudited)

 

 

(In thousands)

Loss recognized in income on interest rate contracts

$

3,366

$

3,641

Gain recognized in AOCI on interest rate contracts (effective portion)

$

(3,370)

$

(1,345)

Loss reclassified from AOCI into income (effective portion)

$

3,360

$

3,647

(Gain) loss recognized in income on interest rate contracts (ineffective portion and amount excluded from effectiveness testing)

$

6

$

(6)